jpp102

Juan P. Palazzo, MD

Contact Dr. Palazzo

132 South 10th Street
Room 285 Main Building
Philadelphia, PA 19107

(215) 955-6352
(215) 923-1969 fax

Most Recent Peer-reviewed Publications

  1. MCM2 expression in serrated polyps demonstrates aberrant cellular proliferation
  2. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1
  3. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer
  4. Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less
  5. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer
  6. Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?
  7. Pathologic spectrum of secretory and mucinous breast lesions
  8. Solitary fibrous tumor of the breast: Report of a case with emphasis on diagnostic role of STAT6 immunostaining
  9. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival from Colon Cancer: A United States Population-Based Study
  10. Ductal carcinoma in situ of the breast: The importance of morphologic and molecular interactions
  11. Solitary fibrous tumor at the anal margin
  12. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast
  13. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer
  14. The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study
  15. Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables
  16. Disseminated histiocytoses biomarkers beyond BRAFV600E: Frequent expression of PD-L1
  17. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
  18. Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy
  19. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients
  20. Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers